Early remodelling of left ventricle and improvement of myocardial performance in patients after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy

被引:28
作者
Veselka, J [1 ]
Honek, T [1 ]
机构
[1] Univ Hosp Motol, Cardiol Sect, Div Cardiac Surg, Prague 15000 5, Czech Republic
关键词
hypertrophic obstructive cardiomyopathy percutaneous transluminal septal myocardial ablation; nonsurgical myocardial reduction; myocardial contrast echocardiography; left ventricular performance;
D O I
10.1016/S0167-5273(02)00381-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Percutaneous transluminal septal myocardial ablation (PTSMA) reduces left ventricular outflow (LVOT) gradient in patients with hypertrophic obstructive cardiomyopathy (HOCM) and leads to symptomatic improvement. Effects of PTSMA on left ventricular performance are currently unknown. The purpose of this study was to evaluate changes in the left ventricular performance using Doppler index of myocardial performance (sum of isovolumic contractile and relaxation times divided by left ventricular ejection time) and left ventricular remodelling after PTSMA for HOCM. Methods: Twenty-five patients with symptomatic HOCM underwent echocardiography-guided PTSMA procedure. Clinical and echocardiographic data were collected at baseline and 3 months after PTSMA. Results: PTSMA procedures were uneventful, in one patient (4%), pacemaker implantation was needed for sustained complete heart block after the procedure. At 3-month follow-up, the maximal LVOT gradient decreased from 68+/-39 to 18.6+/-12 mmHg (P<0.001), the provoked maximal LVOT gradient decreased from 128.8+/-59 to 25+/-21.4 mmHg (P<0.001), and basal septal thickness decreased from 21.7+/-4 to 15.2+/-3 mm (P<0.001). The improvement of the index of myocardial performance (from 0.65+/-7 to 0.56+/-11; P<0.001) was associated with neither significant change in left ventricular ejection fraction nor left ventricular ejection time. There was no significant difference in the left ventricular dimension at baseline and at follow-up. All patients reported a significant improvement in symptoms at follow-up, the mean NYHA class decreased from 2.6+/-0.7 to 1.4+/-0.7 (P<0.001), and the number of patients suffering from episodes of syncope or attacks of dizziness decreased from 13 to two during the 3-month follow-up. Conclusions: PTSMA is a safe, effective and reproducible method in the treatment of highly symptomatic patients with HOCM. This procedure results in a significant relief of symptoms associated with decrease in LVOT gradient and thickness of basal interventricular septum. Positive changes in Doppler IMP suggest possible improvement of left ventricular function. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:27 / 32
页数:6
相关论文
共 22 条
[1]   Pressure-guided nonsurgical myocardial reduction induced by small septal infarctions in hypertrophic obstructive cardiomyopathy [J].
Boekstegers, P ;
Steinbigler, P ;
Molnar, A ;
Schwaiblmair, M ;
Becker, A ;
Knez, A ;
Haberl, R ;
Steinbeck, G .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (03) :846-853
[2]   Targeting percutaneous transluminal septal ablation for hypertrophic obstructive cardiomyopathy by intraprocedural echocardiographic monitoring [J].
Faber, L ;
Ziemssen, P ;
Seggewiss, H .
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2000, 13 (12) :1074-1079
[3]   Hypertrophic cardiomyopathy:: from molecular and genetic mechanisms to clinical management [J].
Ferrari, R ;
Rydén, L .
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2001, 3 (0L) :L1-L2
[4]   Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy [J].
Flores-Ramirez, R ;
Lakkis, NM ;
Middleton, KJ ;
Killip, D ;
Spencer, WH ;
Nagueh, SF .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (01) :208-214
[5]  
Gietzen F. H., 1999, European Heart Journal, V20, P654
[6]   Electromechanical left ventricular behavior after nonsurgical septal reduction in patients with hypertrophic obstructive cardiomyopathy [J].
Henein, MY ;
O'Sullivan, CA ;
Ramzy, IS ;
Sigwart, U ;
Gibson, DG .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (04) :1117-1122
[7]   Nonsurgical septal reduction for symptomatic hypertrophic obstructive cardiomyopathy: The Baylor experience (1996-1999) [J].
Lakkis, N ;
Nagueh, S ;
Killip, D ;
Torre, G ;
Roberts, R ;
Spencer, W .
JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2000, 13 (03) :157-159
[8]   Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy [J].
Lakkis, NM ;
Nagueh, SF ;
Kleiman, NS ;
Killip, D ;
He, ZX ;
Verani, MS ;
Roberts, R ;
Spencer, WH .
CIRCULATION, 1998, 98 (17) :1750-1755
[9]   Pitfalls in clinical recognition and a novel operative approach for hypertrophic cardiomyopathy with severe outflow obstruction due to anomalous papillary muscle [J].
Maron, BJ ;
Nishimura, RA ;
Danielson, GK .
CIRCULATION, 1998, 98 (23) :2505-2508
[10]   The Doppler echocardiographic myocardial performance index predicts left-ventricular dilation and cardiac death after myocardial infarction [J].
Moller, JE ;
Sondergaard, E ;
Poulsen, SH ;
Egstrup, K .
CARDIOLOGY, 2001, 95 (02) :105-111